PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportslarge b-cell lymphoma diffuse
MeSH D016403 - large b-cell lymphoma diffuse
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D016393:B-cell lymphoma
15 Companies
7 Drugs
$
Success rate
D016403: 
Large b-cell lymphoma diffuse
11 Companies
8 Drugs
$
Success rate
D000069293:Plasmablastic lymphoma
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AbbVieEpcoritamab Tepkinly  2023-09-22   
ADC TherapeuticsLoncastuximab tesirine Zynlonta  2021-04-23   
Bristol Myers SquibbLisocabtagene maraleucel Breyanzi  2022-04-04 $400 M Q2/23-Q1/24 
GenentechPolatuzumab vedotin Polivy  2019-06-10   
Glofitamab Columvi  2023-06-15   
GenmabEpcoritamab Epkinly  2023-05-19   
Gilead SciencesAxicabtagene ciloleucel Yescarta  2018-08-23 $1,498 M Y2023 
IncyteTafasitamab Minjuvi  2021-08-26 $37.057 M Y2023 
MorphoSysTafasitamab Monjuvi  2020-07-31   
NovartisTisagenlecleucel Kymriah  2018-08-22 $530 M Q2/20-Q2/23 
Orphan MedicalLoncastuximab tesirine Zynlonta  2022-12-20   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
80%
130/162
Phase 2
39%
73/186
Phase 3
24%
22/91
Approved: 9Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AbbVie
Epcoritamab,
Sodium lactate,
TAPOTOCLAX,
Microcrystalline cellulose
ADC Therapeutics
Loncastuximab tesirine,
Loncastuximab
Bristol Myers Squibb
Lisocabtagene maraleucel,
Sodium lactate,
Microcrystalline cellulose
Genentech
Polatuzumab vedotin,
POLATUZUMAB VEDOTIN-PIIQ,
Glofitamab,
Transplatin,
Tbo-filgrastim,
Navitoclax,
Lenograstim,
Regramostim,
Imgatuzumab,
DACETUZUMAB,
Palifosfamide,
PINATUZUMAB VEDOTIN,
TAPOTOCLAX,
Gcsf
Genmab
Epcoritamab,
Sodium lactate,
Microcrystalline cellulose
Gilead Sciences
Axicabtagene ciloleucel,
Entospletinib,
Epratuzumab,
LANRAPLENIB,
Palifosfamide,
Veltuzumab
Incyte
Tafasitamab,
TAFASITAMAB-CXIX,
Parsaclisib,
Incb053914
MorphoSys
Tafasitamab,
Sodium chloride
Novartis
Tisagenlecleucel,
Benzocaine,
Aglatimagene besadenovec,
Spartalizumab,
Buparlisib,
Vatalanib,
IERAMILIMAB,
SOTRASTAURIN
Roche
Polatuzumab vedotin,
Glofitamab,
Transplatin,
Tbo-filgrastim,
Antithrombin iii,
Idasanutlin,
Lenograstim,
Terfenadine,
Sodium lactate,
Palifosfamide,
Microcrystalline cellulose,
Rituxumab,
Ro6870810
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use